Akero Therapeutics Inc (NASDAQ:AKRO) traded at $26.84 at close of the session on Monday, March 18, made a downward move of -2.54% on its previous day’s price.
Looking at the stock we see that its previous close was $27.54 and the beta (5Y monthly) reads -0.37 . In terms of its 52-week price range, AKRO has a high of $58.38 and a low of $11.25. The company’s stock has gained about 25.36% over that past 30 days.
Akero Therapeutics Inc has a market cap of $1.85 billion and is expected to release its quarterly earnings report on May 13, 2024 – May 17, 2024. Estimates by analysts give the company expected earnings per share (EPS) of -$1, with the EPS growth for the year raised at -$3.97 for 2024 and -$4.33 for next year. These figures represent -37.40% and -9.10% growth in EPS for the two years respectively.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the AKRO stock, short term indicators assign the stock an average of Hold, while medium term indicators assign it an average of Hold. Long term indicators on average place the stock in the category of 50% Sell.
Looking further, we note the current price level is -1.26% off its SMA20 and 12.57% from its 50-day simple moving average. The RSI (14) is pointing at 51.85 while the volatility over the past week is 8.26% and jumps to 10.31% over the past one month. The beta value is -0.37, while the average true range (ATR) is currently pointing at 2.52.
Coming back to Akero Therapeutics Inc (NASDAQ:AKRO), we note that the average 3-month trading volume was 1.39 million, while that of the preceding 10-day period stands at 2.51 million. Current shares outstanding are 68.95 million.
The insiders hold 14.15% of the company’s shares while institutions hold 82.85%. The data shows that short shares as of Feb 29, 2024, stood at 9.4 million at a short ratio of 7.68. This represents a 16.70% short interest in shares outstanding on Feb 29, 2024. Shares short rose in February from the previous month at 7.76 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 14.95% up in year-to-date price movement.
